LSD microdosing carries physiological and psychological risks
the verdict
SUPPORTED
the evidence backs this
confidence 85/100
Current scientific literature and reviews indicate that LSD microdosing carries potential psychological risks (such as anxiety and emotional vulnerability) and physiological safety concerns (such as cardiovascular or receptor-mediated risks), though evidence remains mixed and heavily dependent on study design.
Evidence for · 5
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
2023 · cited by 35
Paper 0 discusses the theoretical physiological risk of valvular heart disease resulting from the chronic activation of serotonin 5-HT2B receptors by psychedelic microdoses.
See more details
More for · 4
Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.
2024 · cited by 10
Paper 2 notes that while microdosing offers potential mental health benefits, users frequently report physiological discomfort and increased anxiety as challenges.
Between enhancement and risk: A critical review of psychedelic microdosing.
2025 · cited by 5
Paper 3 reviews both clinical and observational findings, noting that adverse effects such as anxiety, physical discomfort, and cognitive disruption are frequently reported.
Clinical Research on Lysergic Acid Diethylamide (LSD) in Psychiatry and Neuroscience.
2025 · cited by 4
Paper 5 reviews LSD's clinical potential but explicitly highlights safety considerations, including cardiovascular risks, emotional vulnerability, and hallucinogen-persisting perception disorder.
Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice.
2025 · cited by 1
Paper 7 evaluates the physiological risk of microdosing LSD on cardiovascular health, though noting no significant ventricular or valvular remodeling in its specific mouse model.